Founder, President & CEO, STEMCELL Technologies Inc.
Dr. Allen Eaves, OBC MD PhD FRCPC FACP, was the Founding Director of the Terry Fox Laboratory (1981-2006) and Head of Clinical Hematology, at the University of British Columbia, the Vancouver General Hospital and the BC Cancer Agency (1985-2003). Since 2006, he has been Professor Emeritus of Hematology at UBC.
Dr. Eaves has published over 200 papers with a focus on hematopoiesis and leukemia. He has been elected President of the International Society of Cell Therapy, President of the American Society of Blood and Marrow Transplantation, Treasurer of the Foundation for the Accreditation of Cell Therapy, and was a founding member of Health Canada’s Expert Working Group on the Safety of Organs and Tissues for Transplantation. He has been Chair of the Board of MITACS and sat on the boards of The Canadian Stem Cell Foundation, The Canadian Stem Cell Network, The Centre for Commercialization of Regenerative Medicine, and The Banff International Research Station for Mathematical Innovation and Discovery.
Following mandatory retirement in 2006, he has devoted himself to building STEMCELL Technologies Inc., a company he founded in 1993 to provide novel and standardized tissue culture reagents for stem cell research and regenerative medicine. Always profitable, and with 97% of its sales outside of Canada, STEMCELL is Canada’s largest biotech company with over 1,600 employees and a global network of sales offices and distribution centres serving thousands of customers. Dr. Eaves is passionate about rewarding employment in Canadian industry for those who love science.